Brandon Gavin, SVP & Chief Accounting Officer, sold 14,257 shares of the VEREIT, Inc. (NYSE:VER) in an exchange that happened on August 7th. The stock was sold at an average price of $7.68 per share, amounting to a transaction worth $109,508. The sale was made public in a document filed with the SEC. Additionally, SVP & Chief Accounting Officer Brandon Gavin sold 6,620 shares of this stock in a transaction that took place on August 6th. The stock was sold at an average price of $7.68 per share, for a total exchange amounting to $50,842. After the transaction, the SVP & Chief Accounting Officer Brandon Gavin currently holds 35,462 shares of the company’s stock, which is worth approximately $293271.
With this stock price’s latest movement, it is now -1.31% away from its 1-year high and 26.84% higher than its 1-year low price. In the past seven days, the stock price volatility for VEREIT, Inc. was 1.40%, whereas its volatility in the past 30 days has been 1.59%. This public company’s stock also has a beta score of 0.69. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
VEREIT, Inc. (NYSE:VER) most recently published its quarterly earnings results. The publicly-traded organization reported revenue of $313.26 million for the quarter, compared to the average analyst forecast calling for $288.89 million, which was surpassing the analyst consensus estimate.
Shares of VEREIT, Inc. (VER) plunged -0.48%, amounting to a loss of -$0.040000000000001 per share, to finish the regular trading session at $8.27 on Thursday 03/14/2019. After beginning the session at $8.32, shares of VEREIT, Inc. reached as high as $8.33 during the day, while hitting a 1-day low of $8.26. Trade volume reached 9,058,743 shares against this stock’s average daily volume of 8.34M shares, with a total float of 965.70M. As a consequence of the price decrease, VEREIT, Inc. now has a current market value of 8.00B.
Cronos Group Inc. (NASDAQ:CRON) subtracted -1.51% to its trading price by the close of the most recent session, dropping from its previous closing price of $21.14 to $20.82. This stock increased in value by -6.68% during the last 7-day period, and experienced a loss of 5.85% over the past 30-day period. In the past three months, this stock’s price grew by 62.40% , and added 73.64% to its price during the last six months of trading. CRON demonstrated a yearly price gain of 141.25% , while its year-to-date (YTD) price performance has been up 100.38% . This stock’s price changed by +117.78% compared to its 90-day low, and moved down -17.05% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the CRON stock as “Hold”. In the short-term, Cronos Group Inc. (CRON) has a 20-day average volume of 12,722,570 shares and short-term indicators sets the CRON stock as “ 40% Sell ” on average basis. In the medium-term, CRON stock has a 50-Day average volume of 17,941,459 shares and medium-term indicators gave the average rating of “ 75% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 14,057,254 shares. On average, long-term indicators rated the stock as “67% Buy ”. The overall picture from all short, medium and long-term indicators sets the CRON stock as “24% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on CRON. Jefferies, for example, Initiated its rating on shares of Cronos Group Inc. to a “Underperform”according to a research note from Monday February 25th, 2019. while giving the stock a “Sector Outperform” rating, as stated in a research report from Friday, January 18th, 2019.
In other news related to Cronos Group Inc. stock, Age shares of CRON held by institutions. The total number of institutions who held the CRON shares was , according to most recent SEC filling. During the past quarter, total shares held by institutions with the net change of shares. In the meantime, new institutions bought the shares of Cronos Group Inc. for the first time and 32 institutions sold all their holdings in the company’s common stock. 45 institutions increased their investment in the CRON stock and institutions decreased their investment in the Cronos Group Inc. (CRON)’s stock during the last quarter.